Owlstone Medical
Developer of breath-based volatile organic compound (VOC) research products and services for non-invasive biomarker discovery, analytical method development, and translational studies. Activities include controlled breath sampling, sorbent-based sample handling, high-resolution GC-MS analysis, curation of a chemically validated VOC reference atlas, clinical and preclinical breath studies, and collaborative method development with regulatory agencies.
Industries
Nr. of Employees
medium (51-250)
Patents
Products
Controlled breath-sampling systems and consumables
Sampling hardware and single-use consumables designed for gated tidal-breath collection onto sorbent cartridges for downstream TD-GC-MS analysis.
ReCIVA Breath
A breath collection device that receives purified air from the CASPER Portable Air Supply to capture consistent breath samples from subjects.
ReCIVA Breath Sampler
A breath sampler designed to enable reliable, reproducible, and non-invasive breath sample collection across different clinical settings.
Breath Biopsy
A single-use kit that includes a sterile mouthpiece attachment for the ReCIVA and a Breath Biopsy Cartridge containing four Markes sorbent tubes to capture VOCs.
Breath Biopsy Collection Station
Designed and optimized to ensure a high-quality, reproducible collection of breath samples, incorporating the ReCIVA Breath Sampler and CASPER Portable Air Supply.
Breath Biopsy OMNI
An optimized method for breath analysis supported by specialist expertise in GC-MS use and data analysis for non-invasive biomarker discovery.
Controlled breath-sampling systems and consumables
Sampling hardware and single-use consumables designed for gated tidal-breath collection onto sorbent cartridges for downstream TD-GC-MS analysis.
ReCIVA Breath
A breath collection device that receives purified air from the CASPER Portable Air Supply to capture consistent breath samples from subjects.
ReCIVA Breath Sampler
A breath sampler designed to enable reliable, reproducible, and non-invasive breath sample collection across different clinical settings.
Breath Biopsy
A single-use kit that includes a sterile mouthpiece attachment for the ReCIVA and a Breath Biopsy Cartridge containing four Markes sorbent tubes to capture VOCs.
Breath Biopsy Collection Station
Designed and optimized to ensure a high-quality, reproducible collection of breath samples, incorporating the ReCIVA Breath Sampler and CASPER Portable Air Supply.
Breath Biopsy OMNI
An optimized method for breath analysis supported by specialist expertise in GC-MS use and data analysis for non-invasive biomarker discovery.
Services
Analytical services for untargeted and targeted VOC profiling from breath and in vitro samples, including sample handling, TD-GC-MS analysis, data processing and reporting.
Account-based access to a chemically validated VOC reference database to support compound identification and cross-study comparisons in breath research.
Analytical services for untargeted and targeted VOC profiling from breath and in vitro samples, including sample handling, TD-GC-MS analysis, data processing and reporting.
Account-based access to a chemically validated VOC reference database to support compound identification and cross-study comparisons in breath research.
Expertise Areas
- Breath-based biomarker discovery
- VOC analytical chemistry and method development
- Clinical biomarker validation and correlation with biochemical endpoints
- Preclinical breath sampling in animal models
Key Technologies
- Thermal desorption–gas chromatography–mass spectrometry (TD-GC-MS)
- High-resolution accurate-mass GC-MS
- Multi-bed sorbent tube sampling
- CO2/pressure-triggered breath collection
News & Updates
Received funding to develop a low-cost synthetic-sensor multi-cancer early detection test for stage I detection of 30+ solid tumours and at-home screening.
Received investment to develop a breath-based test for detection and monitoring of Pseudomonas aeruginosa in cystic fibrosis using VOC analysis.
Entered collaboration to develop analytical methods to improve identification of specific chemicals in complex gaseous mixtures to support the VOC reference atlas.
Announced a $27 million USD investment to accelerate development programs in lung cancer, liver disease, and digestive disease diagnostics.
Pre-proof article reporting identification of a breath VOC (putatively 3-pentanone) correlated with biochemical and clinical outcomes in propionic acidemia, demonstrating application of breath sampling and TD-GC-MS in inborn errors of metabolism.
Received funding to develop a low-cost synthetic-sensor multi-cancer early detection test for stage I detection of 30+ solid tumours and at-home screening.
Received investment to develop a breath-based test for detection and monitoring of Pseudomonas aeruginosa in cystic fibrosis using VOC analysis.
Entered collaboration to develop analytical methods to improve identification of specific chemicals in complex gaseous mixtures to support the VOC reference atlas.
Announced a $27 million USD investment to accelerate development programs in lung cancer, liver disease, and digestive disease diagnostics.
Pre-proof article reporting identification of a breath VOC (putatively 3-pentanone) correlated with biochemical and clinical outcomes in propionic acidemia, demonstrating application of breath sampling and TD-GC-MS in inborn errors of metabolism.